ERICA ROSA: Open Payments
NPI 1619574795 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,739 in 77 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,340 · 2025 $1,739
Food & beverage: $1,623Education: $116
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $376 |
| AstraZeneca Pharmaceuticals LP | 12 | $238 |
| Grifols USA, LLC | 14 | $228 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $126 |
| Actelion Pharmaceuticals US, Inc. | 2 | $124 |
| United Therapeutics Corporation | 4 | $103 |
| JAZZ PHARMACEUTICALS INC. | 2 | $62 |
| Lilly USA, LLC | 3 | $58 |
| Verona Pharma, Inc. | 2 | $50 |
Products named: NUCALA, Prolastin-C Liquid, GLASSIA, FASENRA, Tyvaso, OPSUMIT, OFEV, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
